AQR Capital Management »

Relay Therapeutics shares owned by AQR Capital Management

Quarter-by-quarter ownership of Relay Therapeutics (RLAY) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Relay Therapeutics

Jan 2024Mar 2024May 2024Jul 2024Sep 2024100k200k300k400k20k40k60k
Value ($)Share countHistorical RLAY position of AQR Capital Management Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Relay Therapeutics held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relay Therapeutics by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $166k 23k 7.08
2024-06-30 $439k 67k 6.52
2024-03-31 $121k 15k 8.32
2023-12-31 $127k 12k 11.01

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Relay Therapeutics

BlackRock
Vanguard Group
BlackRock
Casdin Capital
Bellevue Group
Jpmorgan Chase & Co
T. Rowe Price Associates
State Street Corporation
Nextech Invest
Tang Capital Management
Braidwell
Citadel Advisors
Geode Capital Management
Eventide Asset Management
Boxer Capital

View all funds holding Relay Therapeutics